Back to Speakers
Jason Temple

Jason Temple

ShareholderBrown & Fortunato
Mon Mar 023:30 PM – 5:00 PM124 B

LEG02: M&A Considerations in Avoiding Government Enforcement Action

When engaging in mergers and acquisitions (M&A) in the healthcare sector, careful attention to regulatory compliance is essential to avoid enforce…When engaging in mergers and acquisitions (M&A) in the healthcare sector, careful attention to regulatory compliance is essential to avoid enforcement actions. Key considerations include thorough due diligence to uncover potential violations of h…When engaging in mergers and acquisitions (M&A) in the healthcare sector, careful attention to regulatory compliance is essential to avoid enforcement actions. Key considerations include thorough due diligence to uncover potential violations of healthcare laws such as the Anti-Kickback Statute, Stark Law, and HIPAA. Parties must evaluate the target’s billing practices, licensure status, and any history of audits or investigations. Ensuring co…When engaging in mergers and acquisitions (M&A) in the healthcare sector, careful attention to regulatory compliance is essential to avoid enforcement actions. Key considerations include thorough due diligence to uncover potential violations of healthcare laws such as the Anti-Kickback Statute, Stark Law, and HIPAA. Parties must evaluate the target’s billing practices, licensure status, and any history of audits or investigations. Ensuring compliance with federal and state fraud and abuse laws is critical, as even inadvertent violations can lead to significant penalties, transaction delays, and materially impact valuation. Awareness of emerging state disclosure requirements for private equity investments is becoming increasingly important. Structuring deals to address identified risks—such as through indemnifications or compliance plans—is also recommended. Post-closing integration should include alignment of compliance programs and staff training. Involving legal and compliance professionals early helps mitigate risk and supports a smoother transition. Ultimately, proactive regulatory planning throughout the M&A process protects both the acquiring and acquired entities from potential enforcement exposure and ensures long-term operational success.Show MoreClick the title to see all detailsShow More

Panel (3 or more speakers; 90 min)Session TypeLegislative Regulatory LegalSession Track
Todd Moody
Jason Temple
Brad Smith
Todd Moody
Todd MoodyShareholder, Brown & Fortunato
Jason Temple
Jason TempleShareholder, Brown & Fortunato
Brad Smith
Brad SmithManaging Director/Partner, Vertess
Todd Moody
Todd MoodyShareholder, Brown & Fortunato
Jason Temple
Jason TempleShareholder, Brown & Fortunato
Brad Smith
Brad SmithManaging Director/Partner, Vertess
Allow Registration:No
Capacity Unlimited:Yes
Do you feel as though there is a topic missing?:No
Please include five learning objectives::Understand (1) DME compliance issues important to M&A; (2) ways parties identify and mitigate compliance risk; (3) impact of compliance on M&A process; (4) compliance risk impact on integration planning; (5) M&A structure options based on compliance risk
Session Handouts:Handout Link